Malalis, Myla .
HRN: 11-66-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2025
METRONIDAZOLE 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
TID
S/P LTCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes